Private Label OTC Giant Stretches For Switch Help

Perrigo Will Pay $2.1Bn In Cash Deal For HRA Pharma

HRA brings needed expertise in OTC switches to Perrigo, which regularly is first to launch generic equivalents for brand switches but its name hasn’t been linked to submitting proposals for making additional drug ingredients available OTC.

• Source: Alamy

Perrigo Company PLC’s planned acquisition of French firm HRA Pharma will not only bring additional products and markets, but also enhance the private label OTC giant’s outlook for being first in the US to introduce additional nonprescription ingredients. 

HRA, officially identified in France as Hera SAS, brings needed expertise in OTC switches to Perrigo, which is regularly is...

More from Deals

Stada Acquires Fortacell To Grow In Balkans

 
• By 

Stada's Serbian subsidiary Hemofarm has enhanced its offering in the dietary supplements category with the acquisition of Fortacell from Goodwill Pharma.

Vision Healthcare Strikes Deals To Expand European Offering

 
• By 

Belgium-based Vision Healthcare has acquired Svenskt Kosttillskott in Sweden and New Care Supplements in the Netherlands.

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

Danone Acquires Belgian Firm Marketing Gut Health Supplement in US

 
• By 

Danone moves into dietary supplements space with deal for The Akkermansia Company marketing patented biotic strain in US, Europe and Asia.

More from Business

Get To Know: Healthy Aging Specialist Prime Fifty

 
• By 

Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By 

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

Church & Dwight’s Options For Vitamin Brands: Divest, Find Partner, Shrink Business

 

Divesting C&D’s vitamin business, says CEO Richard Dierker, is “probably the cleanest option” as brands remain a drag on earnings after second quarter.